Isatin-pyrimidine hybrid derivatives as enoyl acyl carrier protein reductase (InhA) inhibitors against Mycobacterium tuberculosis
Bioorganic Chemistry · 2023
DOI: 10.1016/j.bioorg.2023.106591 ↗Kurz gefasst
Fachartikel in der Zeitschrift Bioorganic Chemistry, 2023. Verfasst von Abdalrahman Khalifa und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmaceutical Chemistry, Faculty of Pharmacy, The British University in Egypt, El-Sherouk City, Cairo 11837, Egypt; The Center for Dru…. Hauptthemen laut MEDLINE: Mycobacterium tuberculosis, Isatin. Die Arbeit wurde bisher 18-mal zitiert (Crossref) und nennt 63 Literaturangaben. Gefördert von: British University in Egypt.
Abstract (Originalsprache)
Tuberculosis is a worldwide problem that impose a burden on the economy due to continuous development of resistant strains. The development of new antitubercular drugs is a need and can be achieved through inhibition of druggable targets. Mycobacterium tuberculosis enoyl acyl carrier protein (ACP) reductase (InhA) is an important enzyme for Mycobacterium tuberculosis survival. In this study, we report the synthesis of isatin derivatives that could treat TB through inhibition of this enzyme. Compound 4l showed IC50 value (0.6 ± 0.94 µM) similar to isoniazid but is also effective against MDR and XDR Mycobacterium tuberculosis strains (MIC of 0.48 and 3.9 µg/mL, respectively). Molecular docking studies suggest that this compound binds through the use of relatively unexplored hydrophobic pocket in the active site. Molecular dynamics was used to investigate and support the stability of 4l complex with the target enzyme. This study paves the way for the design and synthesis of novel antitubercular drugs.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pharmaceutical Chemistry, Faculty of Pharmacy, The British University in Egypt, El-Sherouk City, Cairo 11837, Egypt; The Center for Drug Research and Development (CDRD), Faculty of Pharmacy, The British Un…
- The Regional Center for Mycology & Biotechnology, Al-Azhar University, Cairo, Egypt.
Förderung
- British University in Egypt
Zitieren
APA
Khalifa, A., Khalil, A., Abdel-Aziz, M. M., Albohy, A., & Mohamady, S. (2023). Isatin-pyrimidine hybrid derivatives as enoyl acyl carrier protein reductase (InhA) inhibitors against Mycobacterium tuberculosis. Bioorganic Chemistry. https://doi.org/10.1016/j.bioorg.2023.106591
Vancouver
Khalifa A, Khalil A, Abdel-Aziz MM, Albohy A, Mohamady S. Isatin-pyrimidine hybrid derivatives as enoyl acyl carrier protein reductase (InhA) inhibitors against Mycobacterium tuberculosis. Bioorganic Chemistry. 2023. doi:10.1016/j.bioorg.2023.106591
BibTeX
@article{Khalifa2023,
author = {Khalifa, Abdalrahman and Khalil, Amira and Abdel-Aziz, Marwa M and Albohy, Amgad and Mohamady, Samy},
title = {Isatin-pyrimidine hybrid derivatives as enoyl acyl carrier protein reductase (InhA) inhibitors against Mycobacterium tuberculosis},
journal = {Bioorganic Chemistry},
year = {2023},
doi = {10.1016/j.bioorg.2023.106591}
}
EUVIMED